肥満細胞腫治療の世界市場は、2021年に約430万米ドルと評価され、予測期間の2022年から2028年には3.5%を超える健全な成長率で成長すると予測されています。肥満細胞腫は、血液癌の一種で、一般に炎症やアレルギーに対する体の反応に関与しています。犬の皮膚腫瘍の中で最も多く見られるのがこの種類です。肥満細胞腫は、骨髄、消化管、肝臓、脾臓などの臓器に影響を及ぼすことがあります。世界中で肥満細胞腫の頻度が上昇していることが、世界の肥満細胞腫治療市場の成長を促進すると予測されます。本疾患に関するデータの入手可能性の向上が、世界の肥満細胞腫治療市場の成長を促進すると予測される。肥満細胞腫の治療方法は、より多くのデータが入手可能になるにつれて改善されると予想されます。様々な政府・非政府組織、支援団体、ソーシャルメディアプラットフォームを通じて肥満細胞腫に関する知識が深まることで、治療を希望する人が増加すると予測されます。市場の競合企業は、改良された肥満細胞腫治療の代替品を開発するために多大な努力と試みを行っています。さまざまな規制当局がオーファンドラッグとして数多くのメリットを提供しているため、肥満細胞腫の分野での研究開発がさらに促進されています。将来的には、この点が世界の肥満細胞腫治療市場を前進させると予測されます。しかし、インド、中国、インドネシア、ブラジル、イランなどの新興国では、ペットに影響を与える数多くの病気に対する認識が不足しており、肥満細胞腫治療の代替品の販売を阻害する可能性があります。さらに、これらの国の住民は、病院で受けられる高価な治療法の代金を支払うことができない可能性があります。
肥満細胞腫治療の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。ヨーロッパは、もう1つの有望な市場地域として浮上すると予想されています。 ヨーロッパと北アメリカの肥満細胞腫治療市場は、病気の有病率の上昇、状態の認識の高まり、高度な技術と治療プロセスの利用可能性により発展すると予想されています。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品内容の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Mast Cell Tumors Treatment Market, by Region, 2020-2028 (USD Million)
1.2.2. Mast Cell Tumors Treatment Market, by Drug Class, 2020-2028 (USD Million)
1.2.3. Mast Cell Tumors Treatment Market, by Route of Administration, 2020-2028 (USD Million)
1.2.4. Mast Cell Tumors Treatment Market, by Distribution Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Mast Cell Tumors Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Mast Cell Tumors Treatment Market Dynamics
3.1. Mast Cell Tumors Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Improved Rate of Diagnosis
3.1.1.2. Availability of data about the disease
3.1.2. Market Challenges
3.1.2.1. Lack of knowledge regarding various diseases affecting pet animals
3.1.3. Market Opportunities
3.1.3.1. Efforts and initiatives are made by the market players
Chapter 4. Global Mast Cell Tumors Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Mast Cell Tumors Treatment Market, by Drug Class
6.1. Market Snapshot
6.2. Global Mast Cell Tumors Treatment Market by Drug Class, Performance - Potential Analysis
6.3. Global Mast Cell Tumors Treatment Market Estimates & Forecasts by Drug Class, 2018-2028 (USD Million)
6.4. Mast Cell Tumors Treatment Market, Sub Segment Analysis
6.4.1. Antihistamines
6.4.2. Epinephrine
6.4.3. Steroids
6.4.4. Mast-cell Stabilizers
Chapter 7. Global Mast Cell Tumors Treatment Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Mast Cell Tumors Treatment Market by Route of Administration, Performance - Potential Analysis
7.3. Global Mast Cell Tumors Treatment Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
7.4. Mast Cell Tumors Treatment Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Injectables
7.4.3. Topical
Chapter 8. Global Mast Cell Tumors Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Mast Cell Tumors Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Mast Cell Tumors Treatment Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Million)
8.4. Mast Cell Tumors Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Drug Stores
8.4.4. Online Pharmacies
Chapter 9. Global Mast Cell Tumors Treatment Market, Regional Analysis
9.1. Mast Cell Tumors Treatment Market, Regional Market Snapshot
9.2. North America Mast Cell Tumors Treatment Market
9.2.1. U.S. Mast Cell Tumors Treatment Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2028
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2028
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Mast Cell Tumors Treatment Market
9.3. Europe Mast Cell Tumors Treatment Market Snapshot
9.3.1. U.K. Mast Cell Tumors Treatment Market
9.3.2. Germany Mast Cell Tumors Treatment Market
9.3.3. France Mast Cell Tumors Treatment Market
9.3.4. Spain Mast Cell Tumors Treatment Market
9.3.5. Italy Mast Cell Tumors Treatment Market
9.3.6. Rest of Europe Mast Cell Tumors Treatment Market
9.4. Asia-Pacific Mast Cell Tumors Treatment Market Snapshot
9.4.1. China Mast Cell Tumors Treatment Market
9.4.2. India Mast Cell Tumors Treatment Market
9.4.3. Japan Mast Cell Tumors Treatment Market
9.4.4. Australia Mast Cell Tumors Treatment Market
9.4.5. South Korea Mast Cell Tumors Treatment Market
9.4.6. Rest of Asia Pacific Mast Cell Tumors Treatment Market
9.5. Latin America Mast Cell Tumors Treatment Market Snapshot
9.5.1. Brazil Mast Cell Tumors Treatment Market
9.5.2. Mexico Mast Cell Tumors Treatment Market
9.6. Rest of The World Mast Cell Tumors Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Merck & Co. Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Route of Administration Summary
10.2.1.5. Recent Developments
10.2.2. Pfizer Inc.
10.2.3. EPI Health, LLC
10.2.4. Teva Pharmaceutical Industries Ltd.
10.2.5. Bausch Health Companies Inc.
10.2.6. Novartis AG
10.2.7. Mylan NV
10.2.8. Bayer AG
10.2.9. Sanofi S.A.
10.2.10. Johnson & Johnson
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Mast Cell Tumors Treatment Market, report scope
TABLE 2. Global Mast Cell Tumors Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Mast Cell Tumors Treatment Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
TABLE 4. Global Mast Cell Tumors Treatment Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
TABLE 5. Global Mast Cell Tumors Treatment Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
TABLE 6. Global Mast Cell Tumors Treatment Market estimates & forecasts byApplication 2018-2028 (USD Million)
TABLE 7. Global Mast Cell Tumors Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Mast Cell Tumors Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Mast Cell Tumors Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Mast Cell Tumors Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Mast Cell Tumors Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Mast Cell Tumors Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Mast Cell Tumors Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Mast Cell Tumors Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Mast Cell Tumors Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. Global Mast Cell Tumors Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 18. U.S. Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. U.S. Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. Canada Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 21. Canada Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. Canada Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. UK Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 24. UK Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. UK Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. Germany Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 27. Germany Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. Germany Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. RoE Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 30. RoE Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. RoE Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. China Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 33. China Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. China Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. India Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 36. India Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. India Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. Japan Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 39. Japan Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. Japan Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. RoAPAC Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 42. RoAPAC Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. RoAPAC Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. Brazil Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 45. Brazil Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Brazil Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. Mexico Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 48. Mexico Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. Mexico Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. RoLA Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 51. RoLA Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. RoLA Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. Row Mast Cell Tumors Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 54. Row Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. Row Mast Cell Tumors Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 56. List of secondary sources, used in the study of global Mast Cell Tumors Treatment Market
TABLE 57. List of primary sources, used in the study of global Mast Cell Tumors Treatment Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
List of figures
FIG 1. Global Mast Cell Tumors Treatment Market, research methodology
FIG 2. Global Mast Cell Tumors Treatment Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Mast Cell Tumors Treatment Market, key trends 2021
FIG 5. Global Mast Cell Tumors Treatment Market, growth prospects 2022-2028
FIG 6. Global Mast Cell Tumors Treatment Market, porters 5 force model
FIG 7. Global Mast Cell Tumors Treatment Market, pest analysis
FIG 8. Global Mast Cell Tumors Treatment Market, value chain analysis
FIG 9. Global Mast Cell Tumors Treatment Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Mast Cell Tumors Treatment Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Mast Cell Tumors Treatment Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Mast Cell Tumors Treatment Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Mast Cell Tumors Treatment Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Mast Cell Tumors Treatment Market, regional snapshot 2018 & 2028
FIG 15. North America Mast Cell Tumors Treatment Market2018 & 2028 (USD Million)
FIG 16. Europe Mast Cell Tumors Treatment Market 2018 & 2028 (USD Million)
FIG 17. Asia Pacific Mast Cell Tumors Treatment Market 2018 & 2028 (USD Million)
FIG 18. Latin America Mast Cell Tumors Treatment Market 2018 & 2028 (USD Million)
FIG 19. Global Mast Cell Tumors Treatment Market, company market share analysis (2021)
